ScripNuvation is transitioning into a commercial-stage biopharma with the launch of Ibtrozi (taletrectinib) for the treatment of ROS1-positive non-small cell lung cancer (NSCLC), where it will compete agai
ScripRiding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com
ScripThe Return Of Endemic Preventable Diseases A recent JAMA paper modeling vaccine-eliminated infections in the US brought concerning news. Following the measles outbreak that started in West Texas an
ScripHealth and Human Services Secretary Robert F. Kennedy Jr.’s decision to abruptly retire all 17 members of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practic